Related Experiment Video
Updated: Sep 18, 2025
06:35
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
7.3K
Renal Involvement in Mixed Cryoglobulinemic Vasculitis: Current Perspectives.
Annalisa Villa1,2, Antonietta Gigante1, Chiara Pellicano1
1Department of Transitional and Precision Medicine, Sapienza University of Rome, Viale dell'Università 37, 00185 Rome, Italy.
Journal of Clinical Medicine
|June 26, 2025
Summary
Mixed cryoglobulinemia (MC) involves immune complexes causing vascular damage and potential kidney issues. Management requires a multidisciplinary approach, with ongoing research into new therapies for challenging cases.
Area of Science:
- Nephrology
- Rheumatology
- Immunology
Background:
- Cryoglobulinemia is a rare disorder involving cryoglobulins precipitating at low temperatures.
- Mixed cryoglobulinemia (MC) types II and III are common, linked to autoimmune diseases or infections like Hepatitis C.
- Renal involvement in MC affects 30% of patients and carries a poor prognosis.
Purpose of the Study:
- To provide a comprehensive review of renal involvement in mixed cryoglobulinemia.
- To discuss recent advances in pathophysiology, diagnostics, and therapeutics for MC.
- To highlight evolving epidemiological trends and emerging related conditions.
Main Methods:
- Literature review focusing on pathophysiology, epidemiology, diagnosis, and treatment of MC with renal involvement.
- Analysis of current therapeutic strategies including etiological treatment, B-cell therapy, and supportive care.
- Consideration of ongoing clinical trials for novel therapies.
Main Results:
- MC can lead to significant renal damage through immune complex deposition and vasculitis.
- Hepatitis C virus eradication has shifted the etiological landscape of MC.
- Effective management integrates etiological treatment, B-cell-targeted therapy (e.g., rituximab), and supportive care.
Conclusions:
- Renal involvement in MC is a serious complication requiring a multimodal treatment strategy.
- The understanding and management of MC are evolving with changing epidemiology and new therapeutic options.
- Future research and clinical trials are crucial for optimizing treatment for refractory MC with renal disease.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
25
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
25
01:24Nephrotic Syndrome I : Introduction
36
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
36
01:14Myocarditis III: Medical Management
20
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
20
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
48
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
48
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
64
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
01:17Pericarditis III: Medical Management
32
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
32